November 29, 2025 - 13:08

Amicus Therapeutics has experienced a significant rise in its share price, gaining over 11% in the past month. This upward trend has piqued the interest of investors who are keen to understand the factors contributing to this momentum and the company's outlook moving forward.
The stock's performance is particularly impressive, with a 30-day return of 11.57% and an even more remarkable increase of over 30% in the last 90 days. Despite these gains, the one-year total shareholder return remains a topic of discussion among analysts and investors alike.
As the company continues to make strides in its operations and product development, stakeholders are eager to see how these advancements will impact future performance. The recent uptick in share price reflects growing confidence in Amicus Therapeutics and its potential to deliver value to investors in the evolving biopharmaceutical landscape. The focus now shifts to the company's upcoming announcements and strategic initiatives that may influence its trajectory in the market.
January 13, 2026 - 05:02
G7 Finance Ministers Address Dependence on Critical Minerals from ChinaFinance ministers from the Group of Seven countries convened in Washington on Monday to tackle the pressing issue of their nations` heavy reliance on China for essential minerals. These critical...
January 12, 2026 - 22:06
Start the New Year with a Financial Reset Budget PlanAs the holiday season wraps up, many individuals find themselves facing the all-too-familiar burden of financial stress. With credit card balances to tackle and “buy now, pay later”...
January 12, 2026 - 21:02
Credit Card Stocks Plummet Following Trump's Fee Cap ProposalCredit card stocks sank early Monday after a proposal from President Trump took aim at the fees these companies charge customers. The suggested cap of 10% on transaction fees has sent shockwaves...
January 9, 2026 - 03:08
Aussies Are Cutting Costs but Overlooking a Bigger Financial MistakeIn a bid to save money, many Australians are reducing their daily expenses by skipping coffees and cutting down on unnecessary subscriptions. However, there is a more significant financial issue...